Summit Securities Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
|
|||||
2025
Q1 | – | Sell |
|
|||||
2024
Q4 | $2.02M | Buy |
|
|||||
2024
Q3 | $176K | Buy |
|
|||||
2024
Q2 | $135K | Sell |
|
|||||
2024
Q1 | $667K | Buy |
|
|||||
2023
Q4 | $324K | Sell |
|
|||||
2023
Q3 | $565K | Buy |
|
|||||
2023
Q2 | $480K | Buy |
|
|||||
2023
Q1 | $481K | Sell |
|
|||||
2022
Q4 | $6.09M | Buy |
|
|||||
2022
Q3 | $600K | Sell |
|
|||||
2022
Q2 | $649K | Sell |
|
|||||
2022
Q1 | $759K | Sell |
|
|||||
2021
Q4 | $6.34M | Buy |
|
|||||
2021
Q3 | $5.81M | Buy |
|
|||||
2021
Q2 | $3.68M | Buy |
|
|||||
2021
Q1 | $1.77M | Sell |
|
|||||
2020
Q4 | $3.37M | Sell |
|
|||||
2020
Q3 | $3.67M | Buy |
|
|||||
2020
Q2 | $3.15M | Buy |
|
|||||
2020
Q1 | $628K | Sell |
|
|||||
2019
Q4 | $1.26M | Buy |
|
|||||
2019
Q3 | $596K | Sell |
|
|||||
2019
Q2 | $804K | Sell |
|
|||||
2019
Q1 | $2.85M | Buy |
|
|||||
2018
Q4 | $1.66M | Sell |
|
|||||
2018
Q3 | $2.21M | Buy |
|
|||||
2018
Q2 | $1.02M | Sell |
|
|||||
2018
Q1 | $1.65M | Buy |
|
|||||
2017
Q4 | $552K | Sell |
|
|||||
2017
Q3 | $3.44M | Buy |
|
|||||
2017
Q2 | $411K | Sell |
|
|||||
2017
Q1 | $2.09M | Sell |
|
|||||
2016
Q4 | $4.13M | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $1.39M | Buy |
|
|||||
2016
Q1 | – | Sell |
|
|||||
2015
Q4 | $6.3M | Sell |
|
|||||
2015
Q3 | $8.97M | Sell |
|
|||||
2015
Q2 | $16.9M | Buy |
|
|||||
2015
Q1 | $1K | Sell |
|
|||||
2014
Q4 | $3K | Buy |
|
|||||
2013
Q4 | – | Sell |
|
|||||
2013
Q3 | $6K | Buy |
|